Circular RNAs in the chemoresistance of triple-negative breast cancer: A systematic review

作者全名："Wang, Hongmei; Shan, Xuefeng; Peng, Yang; Zhou, Weiying"

作者地址："[Wang, Hongmei; Zhou, Weiying] Chongqing Med Univ, Coll Pharm, Dept Pharmacol, Chongqing, Peoples R China; [Wang, Hongmei; Zhou, Weiying] Chongqing Med Univ, Chongqing Key Lab Drug Metab, Chongqing, Peoples R China; [Wang, Hongmei; Zhou, Weiying] Chongqing Med Univ, Key Lab Biochem & Mol Pharmacol Chongqing, Chongqing, Peoples R China; [Wang, Hongmei; Shan, Xuefeng] Chongqing Med Univ, Dept Pharm, Affiliated Hosp 1, Chongqing, Peoples R China; [Peng, Yang] Chongqing Med Univ, Dept Endocrine & Breast Surg, Affiliated Hosp 1, Chongqing, Peoples R China; [Zhou, Weiying] Chongqing Med Univ, Coll Pharm, Dept Pharmacol, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China"

通信作者："Zhou, WY (通讯作者)，Chongqing Med Univ, Coll Pharm, Dept Pharmacol, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China."

来源：DRUG DEVELOPMENT RESEARCH

ESI学科分类：PHARMACOLOGY & TOXICOLOGY

WOS号：WOS:000977832200001

JCR分区：Q2

影响因子：3.5

年份：2023

卷号：　

期号：　

开始页：　

结束页：　

文献类型：Review; Early Access

关键词：chemoresistance; circular RNA; systematic review; triple-negative breast cancer

摘要："This study aims to assess studies on circular RNAs (circRNAs) in the chemoresistance of triple-negative breast cancer (TNBC) and provide relevant references for the development of new TNBC chemotherapy sensitivity biomarkers and therapeutic targets. The PubMed, Embase, Web of Knowledge, Cochrane Library, and four Chinese databases were searched up to January 27, 2023, and studies related to TNBC chemoresistance were included. The basic characteristics of the studies and the mechanisms of circRNAs in regulating TNBC chemoresistance were analyzed. A total of 28 studies published between 2018 and 2023 were included, and the chemotherapeutics included adriamycin, paclitaxel, docetaxel, 5-fluorouracil, lapatinib, and so forth. A total of 30 circRNAs were identified, 86.67% (n = 26) of these circRNAs were reported to act as microRNA (miRNA) sponges to regulate chemotherapy sensitivity, while only two circRNAs (circRNA-MTO1 and circRNA-CREIT) interacted with proteins. A total of 14, 12, and 2 circRNAs were reported to be associated with chemoresistance to adriamycin, taxanes, and 5-fluorouracil, respectively. Six circRNAs were found to act as miRNA sponges that promote chemotherapy resistance by regulating the PI3K/Akt signalling pathway. CircRNAs participate in the regulation of TNBC chemoresistance and can be used as biomarkers and therapeutic targets for improving chemotherapy sensitivity. However, further studies are needed to confirm the role of circRNAs in TNBC chemoresistance."

基金机构：　

基金资助正文：